Lack of specific renal haemodynamic effects of different doses of dopamine after infrarenal aortic surgery

被引:24
作者
Girbes, ARJ
Lieverse, AG
Smit, AJ
vanVeldhuisen, DJ
Zwaveling, JH
Meijer, S
Reitsma, WD
机构
[1] UNIV GRONINGEN HOSP,DEPT CARDIOL,NL-9700 RB GRONINGEN,NETHERLANDS
[2] UNIV GRONINGEN HOSP,DEPT INTERNAL MED,NL-9700 RB GRONINGEN,NETHERLANDS
关键词
pharmacology; dopamine; kidney; function; blood flow; surgery; vascular; cardiovascular system; effects;
D O I
10.1093/bja/77.6.753
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Dopamine is administered frequently in the operating theatre and intensive care unit patients undergoing mechanical ventilation with the aim of specifically enhancing renal uncontrolled, open study, sequentially different doses of dopamine (0, 2, 4, 8 and 0 mu g kg(-1) min(-1)) during a 1-h period each. Systemic haemodynamic and renal haemodynamic variables were measured simultaneously using a pulmonary artery catheter and radiopharmaceuticals, respectively. We studied seven haemodynamically stable patients (mean age 66 yr), with a serum creatinine concentration < 160 mu mol litre(-1), after elective infrarenal abdominal aortic reconstruction. All patients received extradural analgesia with bupivacaine and sufentanil, and none had a previous history of heart failure. Dopamine induced a dose-dependent increase in cardiac index which returned to baseline after cessation of the dopamine infusion. Glomerular filtration rate (GFR) increased with all doses of dopamine, whereas renal blood flow (RBF) increased significantly only with the 2- and 4- 9 kg(-1) min(-1) doses. However, the ratio RBF/cardiac output remained unchanged with the 2- and 4-mu g kg(-1) min(-1) doses, but decreased with 8 mu g kg(-1) min(-1) from 14 (1.5) % to 10 (1.3) %. We conclude that dopamine increased RBF and GFR as a result of an increase in cardiac output.
引用
收藏
页码:753 / 757
页数:5
相关论文
共 27 条
[1]  
[Anonymous], NETH J MED
[2]   DETECTION OF RENAL BLOOD-FLOW ABNORMALITIES IN SEPTIC AND CRITICALLY ILL PATIENTS USING A NEWLY DESIGNED INDWELLING THERMODILUTION RENAL-VEIN CATHETER [J].
BRENNER, M ;
SCHAER, GL ;
MALLORY, DL ;
SUFFREDINI, AF ;
PARRILLO, JE .
CHEST, 1990, 98 (01) :170-179
[3]  
DEIGHTON NM, 1992, J PHARMACOL EXP THER, V262, P532
[4]   MECHANISMS OF DECREASED LEFT-VENTRICULAR PRELOAD DURING CONTINUOUS POSITIVE PRESSURE VENTILATION IN ARDS [J].
DHAINAUT, JF ;
DEVAUX, JY ;
MONSALLIER, JF ;
BRUNET, F ;
VILLEMANT, D ;
HUYGHEBAERT, MF .
CHEST, 1986, 90 (01) :74-80
[5]  
DONKER AJM, 1977, NETH J MED, V20, P97
[6]  
DUKE GJ, 1994, CRIT CARE MED, V22, P1919
[7]   RENAL AND ENDOCRINE EFFECTS OF FENOLDOPAM AND METOCLOPRAMIDE IN NORMAL MAN [J].
GIRBES, ARJ ;
SMIT, AJ ;
MEIJER, S ;
REITSMA, WD .
NEPHRON, 1990, 56 (02) :179-185
[8]   RENAL AND NEUROHUMORAL EFFECTS OF IBOPAMINE AND METOCLOPRAMIDE IN NORMAL MAN [J].
GIRBES, ARJ ;
VANVELDHUISEN, DJ ;
SMIT, AJ ;
DRENTBREMER, A ;
MEIJER, S ;
REITSMA, WD .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (06) :701-704
[9]   EFFECTS OF IBOPAMINE ON RENAL HEMODYNAMICS IN PATIENTS WITH SEVERE CONGESTIVE-HEART-FAILURE [J].
GIRBES, ARJ ;
KALISVAART, CJ ;
VANVELDHUISEN, DJ ;
TAN, ET ;
SMIT, AJ ;
REITSMA, WD ;
PASTEUNING, WH .
EUROPEAN HEART JOURNAL, 1993, 14 (02) :279-283
[10]  
GOLDBERG LI, 1972, PHARMACOL REV, V24, P1